Stem Cell Therapy for Chronic Fatigue Syndrome: A Promising Approach

Authors

  • Deby Susanti Pada Vinski Pada Vinski
  • Svetlana Trofimova Institute of Bioregulation and Gerontology, St. Petersburg
  • Jaime Rodriguez Quintosa Efhre International University, Barcelona
  • Andi Kurniawan Nugroho Universitas Semarang, Semarang
  • CA Schroeter Kastanienh of Clinic, Köln Junkersdorf
  • Stevan Jovanovic Institut Médical de Champel, Geneva

DOI:

https://doi.org/10.58344/jws.v3i11.1231

Keywords:

chronic fatigue syndrome, immunomodulation, mesenchymal stem cells, regenerative medicine, stem cell therapy

Abstract

Chronic Fatigue Syndrome (CFS), or Myalgic Encephalomyelitis (ME), is a debilitating condition marked by persistent fatigue, cognitive dysfunction, and chronic pain, severely affecting quality of life. This study explores the potential of mesenchymal stem cell (MSC) therapy as an innovative treatment for CFS. Using a qualitative descriptive design and case studies, data were gathered through interviews, medical record reviews, and observations of patients undergoing MSC therapy. The findings revealed significant improvements in fatigue, cognitive function, and physical well-being, with participants reporting better memory, concentration, reduced pain, and improved daily functioning. While some sleep disturbances persisted, their severity was reduced. These results highlight the potential of MSC therapy to alleviate CFS symptoms and enhance quality of life. Despite its promise, challenges such as high costs, regulatory hurdles, and the need for standardized protocols persist. Further research is required to confirm long-term efficacy and safety, contributing to the growing evidence for regenerative medicine in treating chronic conditions like CFS.

References

Abusalah, M. A. H., Abd Rahman, E. N. S. E., & Choudhary, O. P. (2024). Evolving trends in stem cell therapy: an emerging and promising approach against various diseases. International Journal of Surgery, 10–1097.

Al-Dhalimy, A. M. B., Salim, H. M., Shather, A. H., Naser, I. H., Hizam, M. M., & Alshujery, M. K. (2023). The pathological and therapeutically role of mesenchymal stem cell (MSC)-derived exosome in degenerative diseases; Particular focus on LncRNA and microRNA. Pathology Research and Practice, 250. https://doi.org/10.1016/j.prp.2023.154778

Bested, A. C., & Marshall, L. M. (2015). Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians. Reviews on Environmental Health, 30(4), 223–249.

Carruthers, B. M., Jain, A. K., De Meirleir, K. L., Peterson, D. L., Klimas, N. G., Lerner, A. M., Bested, A. C., Flor-Henry, P., Joshi, P., & Powles, A. C. P. (2003). Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. Journal of Chronic Fatigue Syndrome, 11(1), 7–115.

Cockshell, S. J., & Mathias, J. L. (2010). Cognitive functioning in chronic fatigue syndrome: a meta-analysis. Psychological Medicine, 40(8), 1253–1267.

Cortes Rivera, M., Mastronardi, C., Silva-Aldana, C. T., Arcos-Burgos, M., & Lidbury, B. A. (2019). Myalgic encephalomyelitis/chronic fatigue syndrome: a comprehensive review. Diagnostics, 9(3), 91.

Cuerquis, J., Romieu-Mourez, R., François, M., Routy, J.-P., Young, Y. K., Zhao, J., & Eliopoulos, N. (2014). Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-? and tumor necrosis factor-? stimulation. Cytotherapy, 16(2), 191–202.

Derafsh, E., Ebrahimzadeh, F., Kahrizi, M. saeed, Kayedi, M., Shojaei, N., Rahimi, S., Alesaeidi, S., & Ghafouri, K. (2023). The therapeutic effects of mesenchymal stem cell (MSCs) exosomes in covid-19 disease; Focusing on dexamethasone therapy. Pathology Research and Practice, 251. https://doi.org/10.1016/j.prp.2023.154815

Elder, E., Johnston, A. N. B., Wallis, M., & Crilly, J. (2020). The demoralisation of nurses and medical doctors working in the emergency department: A qualitative descriptive study. International Emergency Nursing, 52, 100841.

Fan, X.-L., Zhang, Y., Li, X., & Fu, Q.-L. (2020). Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy. Cellular and Molecular Life Sciences, 77, 2771–2794.

Gou, Y., Huang, Y., Luo, W., Li, Y., Zhao, P., Zhong, J., Dong, X., Guo, M., Li, A., Hao, A., Zhao, G., Wang, Y., Zhu, Y., Zhang, H., Shi, Y., Wagstaff, W., Luu, H. H., Shi, L. L., Reid, R. R., … Fan, J. (2024). Adipose-derived mesenchymal stem cells (MSCs) are a superior cell source for bone tissue engineering. Bioactive Materials, 34, 51–63. https://doi.org/10.1016/j.bioactmat.2023.12.003

Hoban, D. B., Howard, L., & Dowd, E. (2015). GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson’s disease. Neuroscience, 303, 402–411.

Jason, L. A., & Sunnquist, M. (2018). The development of the DePaul Symptom Questionnaire: Original, expanded, brief, and pediatric versions. Frontiers in Pediatrics, 6, 409729.

Karavitaki, N., & Prete, A. (2024). therapy of glucocorticoid-induced adrenal insufficiency. European Journal of Endocrinology, 190, G25–G51.

Kodama, J., Wilkinson, K. J., & Otsuru, S. (2022). MSC-EV therapy for bone/cartilage diseases. Bone Reports, 17. https://doi.org/10.1016/j.bonr.2022.101636

Marshall-Gradisnik, S., Huth, T., Chacko, A., Johnston, S., Smith, P., & Staines, D. (2016). Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome. The Application of Clinical Genetics, 39–47.

Mehrabadi, A. Z., Ranjbar, R., Farzanehpour, M., Shahriary, A., Dorostkar, R., Hamidinejad, M. A., & Ghaleh, H. E. G. (2022). Therapeutic potential of CAR T cell in malignancies: A scoping review. Biomedicine & Pharmacotherapy, 146, 112512.

Nguyen, T., Johnston, S., Clarke, L., Smith, P., Staines, D., & Marshall-Gradisnik, S. (2017). Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels. Clinical & Experimental Immunology, 187(2), 284–293.

Rahal, A., Kumar, A., Singh, V., Yadav, B., Tiwari, R., Chakraborty, S., & Dhama, K. (2014). Oxidative stress, prooxidants, and antioxidants: the interplay. BioMed Research International, 2014(1), 761264.

Rowe, P. C., Underhill, R. A., Friedman, K. J., Gurwitt, A., Medow, M. S., Schwartz, M. S., Speight, N., Stewart, J. M., Vallings, R., & Rowe, K. S. (2017). Myalgic encephalomyelitis/chronic fatigue syndrome diagnosis and management in young people: a primer. Frontiers in Pediatrics, 5, 121.

Sapag, M. A., Herrera-Luna, Y., Lara-Barba, E., Pradenas, C., García, C., Oyarce, S., Bustamante-Barrientos, F., Elizondo-Vega, R., Altamirano, C., Ortoloff, A., Figueroa-Valdés, A. I., Alcayaga-Miranda, F., Khoury, M., Matas, J., Barahona, M., Djouad, F., Toledo, J., Vega-Letter, A., & Luz-Crawford, P. (2024). sEVs FROM METABOLICALY REPROGRAMMED UC-MSCs AS A POTENTIAL MULTIFUNCIONAL ACELLULAR THERAPY FOR OSTEOARTHRITIS. Cytotherapy, 26(6), S30. https://doi.org/10.1016/j.jcyt.2024.03.051

Tomas, C., Brown, A., Strassheim, V., Elson, J., Newton, J., & Manning, P. (2017). Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PloS One, 12(10), e0186802.

Vaheb, S., Afshin, S., Ghoshouni, H., Ghaffary, E. M., Farzan, M., Shaygannejad, V., Thapa, S., Zabeti, A., & Mirmosayyeb, O. (2024). Neurological efficacy and safety of mesenchymal stem cells (MSCs) therapy in people with multiple sclerosis (pwMS): An updated systematic review and meta-analysis. Multiple Sclerosis and Related Disorders, 87. https://doi.org/10.1016/j.msard.2024.105681

Zhang, Y., Ge, X., Guo, X.-J., Guan, S., Li, X., Gu, W., & Xu, W. (2017). Bone marrow mesenchymal stem cells inhibit the function of dendritic cells by secreting galectin?1. BioMed Research International, 2017(1), 3248605.

Downloads

Published

2024-11-21

How to Cite

Pada Vinski, D. S. P. V., Trofimova, S., Quintosa, J. R., Nugroho, A. K., Schroeter, C., & Jovanovic, S. (2024). Stem Cell Therapy for Chronic Fatigue Syndrome: A Promising Approach. Journal of World Science, 3(11), 1511–1518. https://doi.org/10.58344/jws.v3i11.1231

Most read articles by the same author(s)